Metformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosis

cic.lugarDesarrolloLaboratorio de Zoonosis Parasitarias, Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Mar del Plataes
cic.lugarDesarrolloConsejo Nacional de Investigaciones Científicas y Técnicases
cic.lugarDesarrolloDepartamento de Química, Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Mar del Plataes
cic.lugarDesarrolloHospital Privado de Comunidades
cic.lugarDesarrolloInstituto de Fisiología Experimental, Universidad Nacional de Rosarioes
cic.versioninfo:eu-repo/semantics/acceptedVersiones
dc.date.accessioned2018-05-18T10:54:27Z
dc.date.available2018-05-18T10:54:27Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/7793
dc.titleMetformin exhibits preventive and therapeutic efficacy against experimental cystic echinococcosisen
dc.typeArtículoes
dcterms.abstractMetformin (Met) is an anti-hyperglycemic and potential anti-cancer agent which may exert its anti-proliferative effects via the induction of energetic stress. In this study we investigated the in vitro and in vivo efficacy of Met against the larval stage of Echinococcus granulosus. Metformin showed significant dose- and time-dependent killing effects on in vitro cultured protoscoleces and metacestodes. Notably, the combination of Met together with the minimum effective concentration of ABZSO had a synergistic effect after days 3 and 12 on metacestodes and protoscoleces, respectively. Oral administration of Met (50 mg/kg/day) in E. granulosus-infected mice was highly effective in reducing the weight and number of parasite cysts, yet its combination with the lowest recommended dose of ABZ (5 mg/kg/day) was even more effective. Coincidentally, intracystic Met accumulation was higher in animals treated with both drugs compared to those administered Met alone. Furthermore, the safe plant-derived drug Met exhibited remarkable chemopreventive properties against secondary hydatidosis in mice. In conclusion, based on our experimental data, Met emerges as a promising anti-echinococcal drug as it has proven to efficiently inhibit the development and growth of the E. granulosus larval stage and its combination with ABZ may improve the current anti-parasitic therapy.en
dcterms.creator.authorLoos, Julia Alexandraes
dcterms.creator.authorDávila, Valeria A.es
dcterms.creator.authorRodrígues, Christian R.es
dcterms.creator.authorPetrigh, Rominaes
dcterms.creator.authorZoppi, Jorge A.es
dcterms.creator.authorCrocenzi, Fernando A.es
dcterms.creator.authorCumino, Andrea C.es
dcterms.extent20 p.es
dcterms.identifier.otherDOI:10.1371/journal.pntd.0005370es
dcterms.identifier.urlRecurso Completoes
dcterms.isPartOf.issuevol. 11, no. 3es
dcterms.isPartOf.seriesPLOS Neglected Tropical Diseaseses
dcterms.issued2017-01-19
dcterms.languageIngléses
dcterms.licenseAttribution-NonCommercial-ShareAlike 4.0 International (BY-NC-SA 4.0)es
dcterms.subjectMetforminen
dcterms.subjectEchinococcusen
dcterms.subjectTherapeutic efficacyen
dcterms.subjectPreventive efficacyes

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Loos - Metformin exhibits preventive CAMBIADO CARLO.pdf-PDFA.pdf
Tamaño:
2.18 MB
Formato:
Adobe Portable Document Format
Descripción:
Documento Completo